title: Reply to comment "Comment on Jugun et al.: The safety and efficacy of high-dose daptomycin combined with rifampicin for the treatment of Gram-positive osteoarticular infections" by Lu et al.
authors.affiliation: Orthopaedic Surgery, Geneva University Hospitals, Geneva, Switzerland, ilker.uckay@hcuge.ch.
authors.forename: Ilker
authors.initials: I
authors.lastname: Uçkay
authors.forename: Pierre
authors.initials: P
authors.lastname: Hoffmeyer
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D017576:Daptomycin / Q000627:therapeutic use*; D005260:Female; D016908:Gram-Positive Bacterial Infections / Q000188:drug therapy*; D006801:Humans; D008297:Male; D016459:Prosthesis-Related Infections / Q000188:drug therapy*; D012293:Rifampin / Q000627:therapeutic use*
chemical_list: D000900:Anti-Bacterial Agents; D017576:Daptomycin; D012293:Rifampin